Selected research
Industry Research
Pharmaceutical Grade Niacin Industry Research Report 2026
Market perspective
The global Pharmaceutical Grade Niacin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Grade Niacin is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Grade Niacin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Niacin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Grade Niacin include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Grade Niacin market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharmaceutical Grade Niacin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Grade Niacin Market by Company
Zhejiang Lanbo Biotechnology
Tianjin Zhongrui Pharmaceutical
Lonza
Vertellus
Vanetta
Resonance Specialties
Lasons India
Jubilant Life Sciences
DSM
Brother Enterprises
Pharmaceutical Grade Niacin Segment by Type
Crystal
Powder
Pharmaceutical Grade Niacin Segment by Application
Pharmaceutical Industry
Daily Chemicals
Others
Pharmaceutical Grade Niacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Niacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Niacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Niacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Grade Niacin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Grade Niacin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Grade Niacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Crystal
- Powder
Applications
- Pharmaceutical Industry
- Daily Chemicals
- Others
Companies covered
- Zhejiang Lanbo Biotechnology
- Tianjin Zhongrui Pharmaceutical
- Lonza
- Vertellus
- Vanetta
- Resonance Specialties
- Lasons India
- Jubilant Life Sciences
- DSM
- Brother Enterprises
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Grade Niacin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Crystal
- 2.2.3 Powder
- 2.3 Pharmaceutical Grade Niacin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Daily Chemicals
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Pharmaceutical Grade Niacin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Pharmaceutical Grade Niacin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Grade Niacin Production by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade Niacin Production Value by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Niacin Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Niacin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Niacin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Niacin Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade Niacin Manufacturers Established Date
- 3.8 Global Pharmaceutical Grade Niacin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Lanbo Biotechnology
- 4.1.1 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Company Information
- 4.1.2 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Business Overview
- 4.1.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Lanbo Biotechnology Product Portfolio
- 4.1.5 Zhejiang Lanbo Biotechnology Recent Developments
- 4.2 Tianjin Zhongrui Pharmaceutical
- 4.2.1 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Company Information
- 4.2.2 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Business Overview
- 4.2.3 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Tianjin Zhongrui Pharmaceutical Product Portfolio
- 4.2.5 Tianjin Zhongrui Pharmaceutical Recent Developments
- 4.3 Lonza
- 4.3.1 Lonza Pharmaceutical Grade Niacin Company Information
- 4.3.2 Lonza Pharmaceutical Grade Niacin Business Overview
- 4.3.3 Lonza Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Lonza Product Portfolio
- 4.3.5 Lonza Recent Developments
- 4.4 Vertellus
- 4.4.1 Vertellus Pharmaceutical Grade Niacin Company Information
- 4.4.2 Vertellus Pharmaceutical Grade Niacin Business Overview
- 4.4.3 Vertellus Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Vertellus Product Portfolio
- 4.4.5 Vertellus Recent Developments
- 4.5 Vanetta
- 4.5.1 Vanetta Pharmaceutical Grade Niacin Company Information
- 4.5.2 Vanetta Pharmaceutical Grade Niacin Business Overview
- 4.5.3 Vanetta Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Vanetta Product Portfolio
- 4.5.5 Vanetta Recent Developments
- 4.6 Resonance Specialties
- 4.6.1 Resonance Specialties Pharmaceutical Grade Niacin Company Information
- 4.6.2 Resonance Specialties Pharmaceutical Grade Niacin Business Overview
- 4.6.3 Resonance Specialties Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Resonance Specialties Product Portfolio
- 4.6.5 Resonance Specialties Recent Developments
- 4.7 Lasons India
- 4.7.1 Lasons India Pharmaceutical Grade Niacin Company Information
- 4.7.2 Lasons India Pharmaceutical Grade Niacin Business Overview
- 4.7.3 Lasons India Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Lasons India Product Portfolio
- 4.7.5 Lasons India Recent Developments
- 4.8 Jubilant Life Sciences
- 4.8.1 Jubilant Life Sciences Pharmaceutical Grade Niacin Company Information
- 4.8.2 Jubilant Life Sciences Pharmaceutical Grade Niacin Business Overview
- 4.8.3 Jubilant Life Sciences Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Jubilant Life Sciences Product Portfolio
- 4.8.5 Jubilant Life Sciences Recent Developments
- 4.9 DSM
- 4.9.1 DSM Pharmaceutical Grade Niacin Company Information
- 4.9.2 DSM Pharmaceutical Grade Niacin Business Overview
- 4.9.3 DSM Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 DSM Product Portfolio
- 4.9.5 DSM Recent Developments
- 4.10 Brother Enterprises
- 4.10.1 Brother Enterprises Pharmaceutical Grade Niacin Company Information
- 4.10.2 Brother Enterprises Pharmaceutical Grade Niacin Business Overview
- 4.10.3 Brother Enterprises Pharmaceutical Grade Niacin Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Brother Enterprises Product Portfolio
- 4.10.5 Brother Enterprises Recent Developments
5 Global Pharmaceutical Grade Niacin Production by Region
- 5.1 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Grade Niacin Production by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Grade Niacin Production by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Grade Niacin Production Forecast by Region (2027-2032)
- 5.3 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Pharmaceutical Grade Niacin Production Value by Region: 2021-2032
- 5.4.1 Global Pharmaceutical Grade Niacin Production Value by Region: 2021-2026
- 5.4.2 Global Pharmaceutical Grade Niacin Production Value Forecast by Region (2027-2032)
- 5.5 Global Pharmaceutical Grade Niacin Market Price Analysis by Region (2021-2026)
- 5.6 Global Pharmaceutical Grade Niacin Production and Value, YOY Growth
- 5.6.1 North America Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021-2032)
6 Global Pharmaceutical Grade Niacin Consumption by Region
- 6.1 Global Pharmaceutical Grade Niacin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Grade Niacin Consumption by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Grade Niacin Consumption by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Grade Niacin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Grade Niacin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Grade Niacin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Grade Niacin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Pharmaceutical Grade Niacin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Pharmaceutical Grade Niacin Production by Type (2021-2032)
- 7.1.1 Global Pharmaceutical Grade Niacin Production by Type (2021-2032) & (t)
- 7.1.2 Global Pharmaceutical Grade Niacin Production Market Share by Type (2021-2032)
- 7.2 Global Pharmaceutical Grade Niacin Production Value by Type (2021-2032)
- 7.2.1 Global Pharmaceutical Grade Niacin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Grade Niacin Production Value Market Share by Type (2021-2032)
- 7.3 Global Pharmaceutical Grade Niacin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Pharmaceutical Grade Niacin Production by Application (2021-2032)
- 8.1.1 Global Pharmaceutical Grade Niacin Production by Application (2021-2032) & (t)
- 8.1.2 Global Pharmaceutical Grade Niacin Production Market Share by Application (2021-2032)
- 8.2 Global Pharmaceutical Grade Niacin Production Value by Application (2021-2032)
- 8.2.1 Global Pharmaceutical Grade Niacin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Pharmaceutical Grade Niacin Production Value Market Share by Application (2021-2032)
- 8.3 Global Pharmaceutical Grade Niacin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Pharmaceutical Grade Niacin Value Chain Analysis
- 9.1.1 Pharmaceutical Grade Niacin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Pharmaceutical Grade Niacin Production Mode & Process
- 9.2 Pharmaceutical Grade Niacin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade Niacin Distributors
- 9.2.3 Pharmaceutical Grade Niacin Customers
10 Global Pharmaceutical Grade Niacin Analyzing Market Dynamics
- 10.1 Pharmaceutical Grade Niacin Industry Trends
- 10.2 Pharmaceutical Grade Niacin Industry Drivers
- 10.3 Pharmaceutical Grade Niacin Industry Opportunities and Challenges
- 10.4 Pharmaceutical Grade Niacin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst